NASDAQ · Analyst Forecast

Mangoceuticals, Inc. (MGRX) Stock Forecast & Price Target

$0.16 NASDAQ: MGRX Market Cap $3.56M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Mangoceuticals, Inc. (MGRX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2023$17,878$17,878$17,878—

Mangoceuticals, Inc. (MGRX) forecast — frequently asked questions

How much revenue is Mangoceuticals, Inc. expected to make?

Analysts forecast Mangoceuticals, Inc. (MGRX) revenue of $17,878 in 2023, based on several published estimates.

Analyst forecasts for other Medical - Healthcare Information Services stocks

VEEV forecastGEHC forecastBTSG forecastTEM forecastHNGE forecastHQY forecastDOCS forecastHTFL forecastPRVA forecastCERT forecastAll Medical - Healthcare Information Services stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.